Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

DX-9065a exhibits antithrombotic efficacy and no effects on hemostasis in animal model

Dec. 29, 1997

Tanabe Seiyaku claims new PAI-1 inhibitors

Dec. 24, 1997

FDA issues health advisory for anticoagulants

Dec. 18, 1997

Promising results reported from rhATIII trial

Dec. 18, 1997

Boehringer Mannheim describes antiplatelet agents

Dec. 18, 1997

Phase II trial of Vasoflux begins in acute MI

Dec. 17, 1997

Cytoprotective effects of TTC-909 demonstrated in SHR-SP

Dec. 15, 1997

Integrilin to be reviewed by FDA advisory panel

Dec. 11, 1997

New indication for Neutralase revealed

Dec. 11, 1997

Yamanouchi describes SAR leading to YM-60828, a potent and selective factor Xa inhibitor

Dec. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...